UK life sciences: Catalysing investment and growth

This report makes the case for continued and cost-effective public investment in the life sciences sector. The report aims to inform the Government, UK Research and Innovation (UKRI), and other policy-makers as they prepare for the forthcoming Spending Review and develop new R&D funding plans to reach the target of raising R&D investment to 2.4% of GDP by 2027.

More within